Auf dieser Seite
01AUPH Preis
02Momentaufnahme
03Chart
06Performance
07Bewertung & Kennzahlen
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
AUPH Aurinia Pharmaceuticals Inc - Common Shares
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$15,83
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$10,9052-Wochen-Tief
$19,2552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$2.10B
P/E (TTM)
6.9
EPS (TTM)
$2.29
Umsatz (TTM)
$312M
Ihre Abzeichen
52W-Spanne
$11–$19
Analystenbewertung
BUY
Kursziel
$18
P/E
6.9
ROE
66.1%
Nettogewinnmarge
100.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
AUPH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$15.83
Marktkapitalisierung (MRQ)
$2.10B
P/E (TTM)
6.9
EPS (TTM)
$2.29
Umsatz (TTM)
$312M
ROE (TTM)
66.1%
52W-Spanne
$11–$19
AUPH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$283M2018-12-31 → 2025-12-31
EPS$2.072019-12-31 → 2025-12-31
Nettogewinnmarge100.8%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | AUPH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 6.95-Jahres-Durchschnitt ≈38.7 | ≈38.7 | · | · | |
| P/S (TTM) | 6.85-Jahres-Durchschnitt ≈22.1 | ≈22.1 | 10.3 | Unterbewertet | |
| K/B (MRQ) | 3.45-Jahres-Durchschnitt ≈3.8 | ≈3.8 | 3.7 | Fairer Wert | |
| Price / Cash Flow (Kurs / Cashflow) | 15.35-Jahres-Durchschnitt ≈3.9 | ≈3.9 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 3.45-Jahres-Durchschnitt ≈3.8 | ≈3.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | AUPH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 48.4%5-Jahres-Durchschnitt ≈-111.1% | ≈-111.1% | -588.2% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 54.6%5-Jahres-Durchschnitt ≈-106.8% | ≈-106.8% | -588.2% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 51.5%5-Jahres-Durchschnitt ≈-107.7% | ≈-107.7% | -709.2% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 100.8%5-Jahres-Durchschnitt ≈-93.4% | ≈-93.4% | -507.2% | Spitzenklasse | |
| ROA (TTM) | 48.5%5-Jahres-Durchschnitt ≈-3.0% | ≈-3.0% | -29.6% | Spitzenklasse | |
| ROE (TTM) | 66.1%5-Jahres-Durchschnitt ≈-2.1% | ≈-2.1% | -42.0% | Spitzenklasse | |
| ROIC | 45.4%5-Jahres-Durchschnitt ≈-5.4% | ≈-5.4% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | AUPH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.45-Jahres-Durchschnitt ≈8.0 | ≈8.0 | 9.6 | Geringe Liquidität | |
| Quick Ratio | 0.95-Jahres-Durchschnitt ≈2.4 | ≈2.4 | 6.6 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | AUPH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 20.4%5-Jahres-Durchschnitt ≈54.0% | ≈54.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 28.3%5-Jahres-Durchschnitt ≈51.0% | ≈51.0% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 41.4% | · | · | · | |
| EPS YoY (EPS VjV) | 5075.0% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | 4893.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | AUPH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.2 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 0.85-Jahres-Durchschnitt ≈0.5 | ≈0.5 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$2.2M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
26.8%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $0.28 | $0.24 | 14.4% |
| 31. März 2026 | Mai 11, 2026 | $0.25 | $0.20 | 23.8% |
| 31. Dezember 2025 | $0.26 | $0.22 | 17.6% | |
| 30. September 2025 | $0.23 | $0.16 | 40.9% | |
| 30. Juni 2025 | $0.16 | $0.15 | 7.0% | |
| 31. März 2025 | $0.16 | $0.10 | 56.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $283M | $235M | $176M | $134M | $46M | $50M | $318.0K | |
| Cost of Revenue | $33M | $28M | $14M | $6M | $1M | $0 | $0 | |
| R&D Expense | $33M | $21M | $50M | $45M | $51M | $50M | $53M | |
| SG&A Expense | $102M | $172M | $195M | $196M | $174M | $97M | $22M | |
| Operating Expenses | $178M | $240M | $267M | · | · | $154M | $91M | |
| Operating Income | $105M | $-5M | $-92M | $-111M | $-181M | $-104M | $-91M | |
| Interest Expense | · | · | $3M | $0 | $0 | · | · | |
| Interest Income | $14M | $17M | $17M | $5M | · | · | · | |
| Pretax Income | $114M | $7M | $-77M | $-106M | $-180M | $-103M | $-88M | |
| Income Tax | $-173M | $2M | $551.0K | $2M | $760.0K | $-94.0K | $144.0K | |
| Net Income | $287M | $6M | $-78M | $-108M | $-181M | $-103M | $-88M | |
| EPS (Basic) | $2.14 | $0.04 | $-0.54 | $-0.76 | $-1.40 | $-0.87 | $-0.95 | |
| EPS (Diluted) | $2.07 | $0.04 | $-0.54 | $-0.76 | $-1.40 | $-0.87 | $-0.95 | |
| Shares (Basic) | 134,367,000 | 143,057,000 | 143,236,000 | 141,915,000 | 129,369,000 | 118,473,000 | · | |
| Shares (Diluted) | 138,700,000 | 146,194,000 | 143,236,000 | 141,915,000 | 129,369,000 | 118,473,000 | · | |
| EBITDA | $124M | $15M | · | $-109M | $-181M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $80M | $83M | $49M | $94M | $232M | $272M | $306M | |
| Inventory | $46M | $39M | $40M | $25M | $19M | $14M | $0 | |
| Prepaid Expense | · | · | $9M | $14M | $12M | $7M | $9M | |
| Other Current Assets | $1M | $1M | $1M | $1M | $796.0K | $1M | · | |
| Current Assets | $492M | $447M | $425M | $443M | $513M | $419M | $315M | |
| PP&E (Net) | $2M | $3M | $3M | $4M | $4M | $5M | $93.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $5M | $250.0K | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $836.0K | $179.0K | $157.0K | |
| Intangibles | $4M | $4M | $5M | $6M | $8M | $9M | $9M | |
| Other Non-current Assets | $93.0K | $823.0K | $2M | $13M | $12M | $247.0K | $209.0K | |
| Total Assets | $752M | $551M | $548M | $471M | $543M | $464M | $324M | |
| Accounts Payable | $3M | $5M | $4M | $40M | $35M | $25M | $11M | |
| Accrued Liabilities | $67M | $65M | $50M | · | · | · | · | |
| Current Liabilities | $94M | $98M | $77M | $46M | $41M | $32M | $11M | |
| Capital Leases | $5M | $6M | $7M | $7M | $8M | $8M | $0 | |
| Deferred Tax | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $7M | $9M | $11M | $12M | $16M | $16M | $6M | |
| Total Liabilities | $170M | $173M | $170M | $65M | $64M | $56M | $26M | |
| Retained Earnings | $-649M | $-937M | $-942M | $-864M | $-756M | $-575M | $-472M | |
| AOCI | $-599.0K | $-647.0K | $-730.0K | $-1M | $-852.0K | $-805.0K | $-805.0K | |
| Stockholders' Equity | $581M | $377M | $378M | $405M | $479M | $408M | $299M | |
| Liabilities + Equity | $752M | $551M | $548M | $471M | $543M | $464M | $324M | |
| Shares Outstanding | 132,323,000 | 140,883,000 | 143,833,000 | 142,268,000 | 141,600,000 | 126,725,000 | 111,798,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $19M | $19M | $12M | $3M | $3M | $1M | · | |
| Stock-based Comp | $15M | $32M | $45M | $32M | $31M | $17M | $7M | |
| Deferred Tax | $-176M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $800.0K | $900.0K | $2M | $2M | $2M | $1M | $1M | |
| Other Non-cash | $-9M | $-12M | · | $-6M | · | · | · | |
| Operating Cash Flow | $136M | $44M | $-33M | $-80M | $-158M | $-70M | $-64M | |
| Investing Cash Flow | $-33M | $39M | $-7M | $-61M | $-104M | $-158M | $8M | |
| Stock Issued | $756.0K | $1M | $2M | $2M | $197M | $188M | $223M | |
| Stock Repurchased | $98M | $40M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-97M | $-39M | · | $0 | $197M | · | · | |
| Financing Cash Flow | $-106M | $-49M | $-5M | $2M | $221M | $194M | $244M | |
| Net Change in Cash | $-3M | $35M | $-45M | $-138M | $-40M | $-34M | $188M | |
| Taxes Paid | $3M | $2M | $496.0K | $2M | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 37.1% | -2.0% | · | -83.2% | -396.3% | · | · | |
| Net Margin | 101.5% | 2.5% | · | -80.7% | -396.8% | · | · | |
| Pretax Margin | 40.3% | 3.2% | · | -79.3% | -395.1% | · | · | |
| EBITDA Margin | 43.9% | 6.3% | · | -81.2% | -396.3% | · | · | |
| ROA | 44.1% | 1.1% | · | -21.3% | -35.9% | · | · | |
| ROE | 62.7% | 1.5% | · | -26.1% | -46.6% | · | · | |
| ROIC | 45.4% | -0.96% | · | -28.0% | -37.9% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 4.6 | · | 9.6 | 12.6 | · | · | |
| Quick Ratio | 0.9 | 0.9 | · | 2.0 | 5.7 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.3 | 0.1 | · | · | |
| Inventory Turnover | 0.8 | 0.7 | · | 0.3 | 0.1 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.39 | $2.68 | · | $2.85 | $3.38 | · | · | |
| Revenue / Share | $2.04 | $1.61 | · | $0.94 | · | · | · | |
| Cash Flow / Share | $0.98 | $0.30 | · | $-0.56 | · | · | · | |
| Cash / Share | $0.61 | $0.59 | · | $0.66 | $1.64 | · | · | |
| EPS (TTM) | $2.07 | $0.04 | $-0.54 | $-0.76 | $-1.40 | $-0.87 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.4% | 34.0% | 30.9% | 193.9% | -9.0% | · | · | |
| Revenue CAGR 3Y | 28.3% | 72.8% | 51.9% | · | · | · | · | |
| Revenue CAGR 5Y | 41.4% | · | · | · | · | · | · | |
| EPS YoY | 5075.0% | · | · | · | · | · | · | |
| Net Income YoY | 4893.1% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $283M | $235M | $176M | $134M | $46M | $50M | · | |
| Net Income TTM | $287M | $6M | $-78M | $-108M | $-181M | $-103M | · | |
| Market Cap | $2.11B | $1.27B | · | $615M | $3.24B | · | · | |
| P/E | 7.7 | 224.5 | -16.6 | -5.7 | -16.3 | -15.9 | · | |
| P/S | 7.5 | 5.4 | · | 4.6 | 71.0 | · | · | |
| P/B | 3.6 | 3.4 | · | 1.5 | 6.8 | · | · | |
| P / Tangible Book | 3.7 | 3.4 | 3.5 | 1.5 | 6.9 | 4.4 | · | |
| P / Cash Flow | 15.6 | 28.5 | · | -7.7 | -20.5 | · | · | |
| Earnings Yield | 13.0% | 0.45% | -6.0% | -17.6% | -6.1% | -6.3% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $83M | $78M | $77M | $73M | $70M | $62M | $60M | $68M | $57M | $50M | $45M | $55M | $41M | $34M | $28M | $56M | |
| Cost of Revenue | $7M | $7M | $9M | $8M | $7M | $9M | $6M | $6M | $9M | $8M | $5M | $7M | $2M | $421.0K | $1M | $2M | |
| R&D Expense | $13M | $7M | $11M | $8M | $7M | $6M | $8M | $3M | $4M | $6M | $10M | $14M | $13M | $13M | $10M | $11M | |
| SG&A Expense | $24M | $22M | $29M | $26M | $26M | $20M | $37M | $42M | $45M | $48M | $50M | $48M | $47M | $50M | $47M | $52M | |
| Operating Expenses | $37M | $36M | $44M | $44M | $50M | $41M | $62M | $56M | $59M | $64M | $75M | $71M | $58M | $64M | $57M | $65M | |
| Operating Income | $46M | $41M | $33M | $30M | $20M | $22M | $-2M | $12M | $-2M | $-13M | $-30M | $-16M | $-16M | $-30M | $-28M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1M | $1M | · | $1M | $65.0K | $0 | · | $0 | |
| Interest Income | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | · | · | · | · | |
| Pretax Income | $49M | $44M | $36M | $32M | $22M | $24M | $1M | $15M | $1M | $-10M | $-26M | $-13M | $-12M | $-26M | $-25M | $-8M | |
| Income Tax | $11M | $10M | $-175M | $411.0K | $643.0K | $1M | $-256.0K | $457.0K | $756.0K | $739.0K | $459.0K | $298.0K | $-642.0K | $436.0K | $855.0K | $954.0K | |
| Net Income | $37M | $34M | $211M | $32M | $22M | $23M | $1M | $14M | $722.0K | $-11M | $-27M | $-13M | $-11M | $-26M | $-26M | $-9M | |
| EPS (Basic) | $0.29 | $0.26 | $1.60 | $0.24 | $0.16 | $0.17 | $0.01 | $0.10 | $0.01 | $-0.07 | $-0.19 | $-0.09 | $-0.08 | $-0.18 | $-0.18 | $-0.06 | |
| EPS (Diluted) | $0.28 | $0.25 | $1.53 | $0.23 | $0.16 | $0.16 | $0.01 | $0.10 | $0.01 | $-0.07 | $-0.19 | $-0.09 | $-0.08 | $-0.18 | $-0.18 | $-0.06 | |
| Shares (Basic) | 130,081,000 | 132,375,000 | · | 131,808,000 | 134,873,000 | 138,917,000 | · | 143,051,000 | 143,327,000 | 144,013,000 | · | 142,847,000 | 142,777,000 | 142,641,000 | · | 141,856,000 | |
| Shares (Diluted) | 133,530,000 | 137,639,000 | · | 136,008,000 | 137,526,000 | 143,199,000 | · | 145,651,000 | 144,110,000 | 144,013,000 | · | 142,847,000 | 142,777,000 | 142,641,000 | · | 141,856,000 | |
| EBITDA | $46M | $46M | · | $30M | $20M | $27M | · | $12M | $-2M | $-13M | · | $-16M | $-16M | $-30M | · | $-9M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $180M | $41M | $80M | $73M | $53M | $66M | $83M | $37M | $33M | $64M | $49M | $46M | $81M | $88M | $94M | $85M | |
| Inventory | $45M | $46M | $46M | $45M | $47M | $46M | $39M | $39M | $39M | $40M | · | $33M | $33M | $32M | · | $25M | |
| Prepaid Expense | · | · | · | · | · | · | · | · | $8M | $8M | · | $16M | $11M | $10M | · | $12M | |
| Other Current Assets | $1M | $2M | $1M | $301.0K | $665.0K | $781.0K | $1M | $3M | $7M | $2M | · | $2M | $1M | $1M | · | $4M | |
| Current Assets | $541M | $480M | $492M | $439M | $409M | $406M | $447M | $440M | $410M | $398M | · | $426M | $416M | $424M | · | $460M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | · | $3M | $4M | $4M | · | $4M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $1M | |
| Intangibles | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | · | $5M | $6M | $6M | · | $7M | |
| Other Non-current Assets | $93.0K | $93.0K | $93.0K | $93.0K | $93.0K | $823.0K | $823.0K | $868.0K | $867.0K | $2M | · | $2M | $2M | $13M | · | $13M | |
| Total Assets | $792M | $724M | $752M | $528M | $503M | $505M | $551M | $549M | $524M | $517M | · | $555M | $549M | $452M | · | $488M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $3M | $4M | $5M | $57M | $56M | $50M | · | $52M | $41M | $36M | · | $40M | |
| Accrued Liabilities | $64M | $58M | $67M | $50M | $50M | $42M | $65M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $100M | $87M | $94M | $76M | $78M | $68M | $98M | $79M | $77M | $71M | · | $74M | $62M | $42M | · | $42M | |
| Capital Leases | $2M | $2M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Deferred Tax | $23M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $945.0K | $7M | $7M | $12M | $12M | $11M | $9M | $11M | $11M | $12M | · | $10M | $9M | $12M | · | $16M | |
| Total Liabilities | $177M | $156M | $170M | $162M | $167M | $155M | $173M | $161M | $159M | $157M | · | $163M | $157M | $61M | · | $65M | |
| Retained Earnings | $-578M | $-615M | $-649M | $-860M | $-892M | $-913M | $-937M | $-938M | $-952M | $-953M | · | $-915M | $-902M | $-891M | · | $-838M | |
| AOCI | $-977.0K | $-880.0K | $-599.0K | $-749.0K | $-905.0K | $-825.0K | $-647.0K | $-385.0K | $-859.0K | $-854.0K | · | $-947.0K | $-1M | $-988.0K | · | $-2M | |
| Stockholders' Equity | $615M | $568M | $581M | $366M | $335M | $350M | $377M | $388M | $365M | $359M | $378M | $392M | $392M | $390M | $405M | $423M | |
| Liabilities + Equity | $792M | $724M | $752M | $528M | $503M | $505M | $551M | $549M | $524M | $517M | · | $555M | $549M | $452M | · | $488M | |
| Shares Outstanding | 132,907,000 | 130,771,000 | 132,323,000 | 131,841,000 | 132,668,000 | 137,747,000 | 140,883,000 | 143,109,000 | 142,984,000 | 143,690,000 | 143,833,000 | 143,605,000 | 143,369,000 | 143,029,000 | 142,268,000 | 142,110,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | · | · | · | · | · | |
| Stock-based Comp | $3M | $-866.0K | $7M | $6M | $5M | $-3M | $9M | $8M | $9M | $6M | $12M | $12M | $12M | $9M | $7M | $8M | |
| Deferred Tax | $11M | $9M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $300.0K | $200.0K | $200.0K | $200.0K | $200.0K | $500.0K | $500.0K | $500.0K | $600.0K | $500.0K | |
| Other Non-cash | · | $-15M | · | · | · | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $53M | $33M | $46M | $44M | $44M | $1M | $30M | $17M | $16M | $-19M | $14M | $-13M | $-3M | $-32M | $10M | $-15M | |
| Investing Cash Flow | $81M | $-18M | $-37M | $-14M | $-13M | $31M | $39M | $-11M | $-39M | $49M | $-6M | $-20M | $-6M | $25M | $-3M | $-50M | |
| Stock Issued | · | · | $355.0K | $0 | · | · | $381.0K | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $39M | $36M | $0 | $9M | $43M | $47M | $22M | $0 | $6M | $12M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-36M | · | · | · | $-47M | · | · | · | $-12M | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $-54M | $-2M | $-10M | $-44M | $-49M | $-23M | $-3M | $-8M | $-15M | $-6M | $-2M | $1M | $2M | $688.0K | $0 | |
| Net Change in Cash | $139M | $-39M | $7M | $20M | $-13M | $-17M | $46M | $4M | $-31M | $16M | $2M | $-35M | $-7M | $-5M | $8M | $-66M | |
| Taxes Paid | $-4M | $1M | $-276.0K | $2M | $820.0K | $246.0K | $725.0K | $0 | $1M | $0 | $157.0K | $62.0K | $276.0K | $1.0K | $1M | $0 |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 55.7% | 53.3% | · | 40.5% | 28.7% | 35.0% | · | 17.3% | -2.6% | -26.4% | · | -29.8% | -39.0% | -86.0% | · | -17.0% | |
| Net Margin | 45.0% | 44.2% | · | 43.0% | 30.7% | 37.4% | · | 21.2% | 1.3% | -21.4% | · | -24.7% | -27.7% | -76.2% | · | -16.1% | |
| Pretax Margin | 58.6% | 56.5% | · | 43.5% | 31.6% | 39.0% | · | 21.9% | 2.6% | -19.9% | · | -24.1% | -29.2% | -74.9% | · | -14.4% | |
| EBITDA Margin | 55.7% | 59.5% | · | 40.5% | 28.7% | 42.8% | · | 17.3% | -2.6% | -26.4% | · | -29.8% | -39.0% | -86.0% | · | -17.0% | |
| ROA | 5.8% | 5.6% | · | 5.9% | 4.2% | 4.6% | · | 2.6% | 0.13% | -2.2% | · | -2.6% | -2.2% | -5.5% | · | -2.1% | |
| ROE | 7.9% | 7.5% | · | 8.4% | 6.2% | 6.6% | · | 3.7% | 0.19% | -2.9% | · | -3.3% | -2.8% | -6.2% | · | -2.5% | |
| ROIC | 5.8% | 5.7% | · | 8.0% | 5.8% | 6.0% | · | 2.9% | -0.20% | -4.0% | · | -4.2% | -3.9% | -7.7% | · | -2.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 5.5 | · | 5.8 | 5.2 | 5.9 | · | 5.6 | 5.3 | 5.6 | · | 5.8 | 6.7 | 10.1 | · | 11.0 | |
| Quick Ratio | 1.8 | 0.5 | · | 1.0 | 0.7 | 1.0 | · | 0.5 | 0.4 | 0.9 | · | 0.6 | 1.3 | 2.1 | · | 2.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -1.3 | -10.3 | · | -11.6 | -248.8 | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.0 | · | 0.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.63 | $4.34 | · | $2.77 | $2.53 | $2.54 | · | $2.71 | $2.55 | $2.50 | · | $2.73 | $2.74 | $2.73 | · | $2.98 | |
| Revenue / Share | $0.62 | $0.56 | · | $0.54 | $0.51 | $0.44 | · | $0.47 | $0.40 | $0.35 | · | $0.38 | $0.29 | $0.24 | · | $0.39 | |
| Cash Flow / Share | · | $0.24 | · | · | · | $0.01 | · | · | · | $-0.13 | · | · | · | $-0.22 | · | · | |
| Cash / Share | $1.35 | $0.31 | · | $0.55 | $0.40 | $0.48 | · | $0.26 | $0.23 | $0.44 | · | $0.32 | $0.57 | $0.62 | · | $0.60 | |
| EPS (TTM) | $2.29 | $2.17 | · | $0.56 | $0.43 | $0.28 | · | $-0.15 | $-0.34 | $-0.43 | · | $-0.53 | $-0.50 | $-0.67 | · | $-0.82 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $312M | $298M | · | $266M | $260M | $247M | · | $220M | $207M | $191M | · | $159M | $160M | $147M | · | $129M | |
| Net Income TTM | $314M | $298M | · | $78M | $61M | $40M | · | $-23M | $-50M | $-63M | · | $-77M | $-73M | $-97M | · | $-115M | |
| Market Cap | $2.26B | $1.94B | · | $1.46B | $1.12B | $1.11B | · | $1.05B | $816M | $720M | · | $1.12B | $1.39B | $1.57B | · | $1.07B | |
| P/E | 7.4 | 6.8 | · | 19.7 | 19.7 | 28.7 | · | -48.9 | -16.8 | -11.7 | · | -14.7 | -19.4 | -16.4 | · | -9.2 | |
| P/S | 7.2 | 6.5 | · | 5.5 | 4.3 | 4.5 | · | 4.8 | 3.9 | 3.8 | · | 7.0 | 8.7 | 10.7 | · | 8.3 | |
| P/B | 3.7 | 3.4 | · | 4.0 | 3.4 | 3.2 | · | 2.7 | 2.2 | 2.0 | · | 2.8 | 3.5 | 4.0 | · | 2.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 4.0 | 3.4 | 3.2 | · | 2.7 | 2.3 | 2.0 | · | 2.9 | 3.6 | 4.1 | · | 2.6 | |
| P / Cash Flow | · | 59.5 | · | · | · | 851.9 | · | · | · | -38.7 | · | · | · | -49.5 | · | · | |
| Earnings Yield | 13.5% | 14.6% | · | 5.1% | 5.1% | 3.5% | · | -2.1% | -5.9% | -8.6% | · | -6.8% | -5.2% | -6.1% | · | -10.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $283M | $235M | $176M | $134M | $46M |
| Betriebsgewinnmarge % | 37.1% | -2.0% | · | -83.2% | -396.3% |
| Nettoergebnis | $287M | $6M | $-78M | $-108M | $-181M |
| Verwässerte EPS | $2.07 | $0.04 | $-0.54 | $-0.76 | $-1.40 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.2 | 4.6 | · | 9.6 | 12.6 |
| Quick Ratio | 0.9 | 0.9 | · | 2.0 | 5.7 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 302 Einreicher · $1.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
302
Gehaltener Wert
$1.4B
Neue Positionen
46
Geschlossene Positionen
25
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (+1 vs. Vorquartal) | 25 (-3 vs. Vorquartal) | 110 (+11 vs. Vorquartal) | 80 (0 vs. Vorquartal) | +5.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $221.358.479 | 13.044.106 | 15,74% | Aktien |
| BlackRock, Inc. | $139.036.652 | 8.193.085 | 9,89% | Aktien |
| GOLDMAN SACHS GROUP INC | $95.361.236 | 5.619.401 | 6,78% | Aktien |
| NEA Management Company, LLC | $67.368.083 | 3.969.834 | 4,79% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $58.843.713 | 3.467.514 | 4,19% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $55.391.132 | 3.264.062 | 3,94% | Aktien |
| STATE STREET CORP | $43.945.767 | 2.589.615 | 3,13% | Aktien |
| MORGAN STANLEY | $39.170.903 | 2.308.244 | 2,79% | Aktien |
| MARSHALL WACE, LLP | $34.686.798 | 2.044.007 | 2,47% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $28.864.885 | 1.701.152 | 2,05% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $26.270.154 | 1.548.035 | 1,87% | Aktien |
| D. E. Shaw & Co., Inc. | $23.901.498 | 1.408.456 | 1,70% | Aktien |
| VANGUARD GROUP INC | $23.125.650 | 1.449.884 | 1,64% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23.062.705 | 1.359.028 | 1,64% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $20.898.827 | 1.231.516 | 1,49% | Aktien |
| TWO SIGMA ADVISERS, LP | $20.827.510 | 1.305.800 | 1,48% | Aktien |
| KOTLER KEVIN | $19.536.294 | 1.224.846 | 1,39% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $18.573.241 | 1.094.475 | 1,32% | Aktien |
| Caption Management, LLC | $17.105.760 | 1.008.000 | 1,22% | Verkaufsoption |
| NOMURA HOLDINGS INC | $16.606.876 | 978.602 | 1,18% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $16.100.305 | 948.751 | 1,15% | Aktien |
| NORTHERN TRUST CORP | $14.654.732 | 863.567 | 1,04% | Aktien |
| Allianz Asset Management GmbH | $14.284.175 | 841.731 | 1,02% | Aktien |
| Nuveen, LLC | $13.795.168 | 812.915 | 0,98% | Aktien |
| JANUS HENDERSON GROUP PLC | $11.225.433 | 757.435 | 0,80% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $10.124.607 | 596.618 | 0,72% | Aktien |
| PRUDENTIAL FINANCIAL INC | $9.882.395 | 582.345 | 0,70% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $9.630.339 | 567.492 | 0,68% | Aktien |
| Hillsdale Investment Management Inc. | $9.348.773 | 550.900 | 0,66% | Aktien |
| Qube Research & Technologies Ltd | $8.145.091 | 479.970 | 0,58% | Aktien |
| Woodline Partners LP | $7.742.715 | 456.259 | 0,55% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.568.450 | 445.990 | 0,54% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $7.416.518 | 437.037 | 0,53% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $7.070.228 | 416.631 | 0,50% | Aktien |
| WELLS FARGO & COMPANY/MN | $6.988.671 | 411.825 | 0,50% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $6.931.447 | 408.453 | 0,49% | Aktien |
| FMR LLC | $6.321.004 | 372.481 | 0,45% | Aktien |
| RITHOLTZ WEALTH MANAGEMENT | $6.161.060 | 363.056 | 0,44% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $6.150.200 | 362.416 | 0,44% | Aktien |
| IFP Advisors, Inc | $6.136.929 | 361.634 | 0,44% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $6.034.057 | 355.572 | 0,43% | Aktien |
| Bank of New York Mellon Corp | $5.954.047 | 350.857 | 0,42% | Aktien |
| Norris Financial Group, LLC | $5.809.357 | 342.331 | 0,41% | Aktien |
| Squarepoint Ops LLC | $5.386.787 | 317.430 | 0,38% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $5.270.275 | 310.564 | 0,37% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $5.048.729 | 296.200 | 0,36% | Aktien |
| JPMORGAN CHASE & CO | $4.975.885 | 291.351 | 0,35% | Aktien |
| PDT Partners, LLC | $4.505.382 | 265.491 | 0,32% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $4.475.719 | 263.743 | 0,32% | Aktien |
| NAVELLIER & ASSOCIATES INC | $4.363.700 | 257.142 | 0,31% | Aktien |
Aktivisten & 5%+-Eigentümer 8 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Chin Kyu Huh, ILJIN GLS Co., Ltd., ILJIN SNT Co., Ltd., ILJIN Steel Co., Ltd., Sae Kyoung Huh, Seoung Eun Huh | 26. August 2026 | 4,40% | Änderung | · | SEC |
| TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, TANG CAPITAL PARTNERS, LP, TANG CAPITAL PARTNERS INTERNATIONAL, LP, TANG CAPITAL PARTNERS III, INC, TANG CAPITAL PARTNERS IV, INC ×5 Einreichungen | 4. Juni 2026 | 10,00% | Änderung | Passive Anlage | SEC |
| ILJIN SNT Co., Ltd., ILJIN Steel Co., Ltd., ILJIN GLS Co., Ltd., Sae Kyoung Huh, Seoung Eun Huh, Chin Kyu Huh ×3 Einreichungen | 13. August 2025 | 5,00% | Änderung | · | SEC |
| (voluntary) ILJIN SNT Co., Ltd., (voluntary) ILJIN Semiconductor Co., Ltd., (voluntary) ILJIN Steel Co., Ltd., (voluntary) ILJIN GLS Co., Ltd.*, (voluntary) Sae Kyoung Huh, (voluntary) Seoung Eun Huh, (voluntary) Chin Kyu Huh ×14 Einreichungen | 20. März 2024 | · | Erste Einreichung | · | SEC |
| 11. März 2021 | · | Erste Einreichung | · | SEC | |
| ROBERT W. DUGGAN, GENIUS INC. ×3 Einreichungen | 18. Januar 2019 | · | Erste Einreichung | · | SEC |
| ILJIN Life Science Co., Ltd., ILJIN SNT Co., Ltd., Chin Kyu Huh ×3 Einreichungen | 27. März 2017 | · | Erste Einreichung | · | SEC |
| Growth Equity Opportunities Fund III, LLC, New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, M. James Barrett, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, David M. Mott, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 9. Januar 2017 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 13 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Peter Greenleaf | Chief Executive Officer | 27. Februar 2026 A | 1.840.379 | 0 | 0 | $0 |
| Michael S Hearne | Chief Financial Officer | 18. Mai 2026 A | 116.144 | 0 | 0 | $0 |
| Joseph M Miller | Chief Financial Officer | 27. Februar 2026 A | 576.421 | 0 | 0 | $0 |
| Ryan Cole | Chief Operating Officer | 18. Mai 2026 A | 116.144 | 0 | 0 | $0 |
| Matthew Maxwell Donley | Chief Operating Officer | 27. Februar 2026 A | 680.299 | 0 | 0 | $0 |
| Stephen P. Robertson | Chief Legal Officer | 10. September 2026 S | 588.848 | 0 | 2 | $-546.373 |
| Greg Keenan | SVP, Chief Medical Officer | 6. März 2026 F | 154.449 | 0 | 0 | $0 |
| Scott Michael Habig | Chief Commercial Officer | 6. August 2024 S | 456.338 | 0 | 0 | $0 |
| Volker Knappertz | EVP, Research and Development | 27. Februar 2024 S | 319.128 | 0 | 0 | $0 |
| Michael Robert Martin | Chief Business Officer | 2. März 2023 A | 259.162 | 0 | 0 | $0 |
| Neil Solomons | Chief Medical Officer | 2. März 2022 A | 90.953 | 0 | 0 | $0 |
| Robert Bindert Huizinga | EVP of Research | 2. März 2022 A | 69.379 | 0 | 0 | $0 |
| Massimilano Colao | Chief Commercial Officer | 2. März 2022 A | 13.495 | 0 | 0 | $0 |
| Kathleen Goetz | Direktor | 4. Juni 2026 A | · | 0 | 0 | $0 |
| Jeffrey Allen Bailey | Direktor | 4. Juni 2026 A | 22.775 | 0 | 0 | $0 |
| Craig A Johnson | Direktor | 4. Juni 2026 A | 14.592 | 0 | 0 | $0 |
| Tina Susan Nova | Direktor | 4. Juni 2026 A | · | 0 | 0 | $0 |
| KEVIN TANG | Direktor | 3. März 2026 P | 12.229.500 | 6 | 0 | $12.688.806 |
| David R.W. Jayne | Direktor | 21. November 2024 A | 56.499 | 0 | 0 | $0 |
| Jill Leversage | Direktor | 21. November 2024 A | 25.053 | 0 | 0 | $0 |
| Karen L. Smith | Direktor | 21. November 2024 A | 24.807 | 0 | 0 | $0 |
| Brinda Balakrishnan | Direktor | 21. Mai 2024 S | 17.523 | 0 | 0 | $0 |
| Hector R. Mackay-Dunn | Direktor | 21. Mai 2024 S | 18.595 | 0 | 0 | $0 |
| Daniel Billen | Direktor | 21. Mai 2024 S | 28.141 | 0 | 0 | $0 |
| Robert T Foster | Direktor | 21. September 2023 A | · | 0 | 0 | $0 |
| Joseph P Hagan | Direktor | 18. Mai 2023 M | 11.961 | 0 | 0 | $0 |
| George M Milne JR | Direktor | 18. Mai 2023 M | 78.733 | 0 | 0 | $0 |
| Timothy P Walbert | Direktor | 18. Mai 2022 A | · | 0 | 0 | $0 |
| Michael R Hayden | Direktor | 29. Januar 2021 M | 95.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 26 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,30% | 85.786 NS | 31. Juli 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,42% | 17.341 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,35% | 58.273 SH | 2. Oktober 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 85.377 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,14% | 9.419 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,14% | 867.868 SH | 11. September 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,13% | 55.060 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,13% | 1.121.260 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 127.913 SH | 19. August 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,11% | 29.600 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 108.272 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,06% | 3.050.057 SH | 11. September 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 29.291 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 686.507 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,06% | 57.015 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 23.036 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 320.043 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 50.551 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 7.676 SH | 10. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 8.058 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 38.727 SH | 9. September 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.589 SH | 19. August 2026 | Täglich |
| SVAL · iShares Trust | · | 39.450 SH | 3. September 2026 | Täglich |
| ISCB · iShares Trust | · | 4.948 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 8.178 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 43.709 SH | 1. September 2026 | Täglich |
AUPH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$17.00
+7,4%
3 23,1%
Starker Kauf
7 53,8%
Kauf
3 23,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-02Mittelwert-Ziel $17.86 +12,8%
← Unter allen Zielen
Aktueller Preis $15.83
Tief$16.00
Mittelwert$17.86
Hoch$21.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Abgelaufen
Risiko 1
Belohnung 2,77
Einstieg
$15.19
R:R 2,77
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 5,00
Einstieg
$15.61
R:R 5,00
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026